JAK2 and lung carcinoma: By stimulating the JAK2/STAT3-C/EBPβ-IL6 pathway, IL-6 can promote the release of additional IL-6, creating a positive feedback loop in TAMs; thus, it promotes EMT, invasion, and migration of lung cancer in vivo and in vitro.